Alkaloid AD SkopjeXMAE:ALK +0.22%88 Days Payable is 134.67 as of Mar. 2026, which is 23% above its 10-year median of 109.80. GuruFocus rates XMAE:ALK with a GF Score™ of 88/100 and a GF Value™ of MKD27,213.74 (Modestly Undervalued). Among 921 Drug Manufacturers companies, Alkaloid AD Skopje ranks better than 66.45% on this metric.
The historical rank and industry rank for Alkaloid AD Skopje's Days Payable or its related term are showing as below:
XMAE:ALK'
s Days Payable Range Over the Past 10 Years
Min: 97.37 Med: 109.8 Max: 121.1
Current: 121.1
During the past 13 years, Alkaloid AD Skopje's highest Days Payable was 121.10. The lowest was 97.37. And the median was 109.80.
XMAE:ALK's Days Payable is ranked better than 66.45% of 921
companies
in the Drug Manufacturers industry
Industry Median: 90.69
vs XMAE:ALK: 121.10
Alkaloid AD Skopje's Days Payable
increased
from Mar. 2025 (101.69) to Mar. 2026 (134.67).
It may suggest that Alkaloid AD Skopjedelayed paying its suppliers.
Alkaloid AD Skopje Days Payable Related Terms
Alkaloid AD Skopje Days Payable Historical Data
* Premium members only.
The historical data trend for Alkaloid AD Skopje's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XMAE:ALK vs ZTS, UTHR, VTRS: Days Payable Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Alkaloid AD Skopje's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Alkaloid AD Skopje Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Alkaloid AD Skopje's Days Payable distribution charts can be found below:
* The bar in red indicates where Alkaloid AD Skopje's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Alkaloid AD Skopje's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Alkaloid AD Skopje (XMAE:ALK) has a Days Payable of 134.67 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Alkaloid AD Skopje and its competitors. This is 23% above median its historical median of 109.80. Over the past decade, Alkaloid AD Skopje's Days Payable has ranged from 97.37 to 121.10. According to the industry distribution chart, Alkaloid AD Skopje ranks #309 out of 921 companies in the Drug Manufacturers industry, placing it in the top 33.6%.
Is Alkaloid AD Skopje's Days Payable too high?
Alkaloid AD Skopje's current Days Payable of 134.67 is 23% above median its 10-year median of 109.80. Over the past 10 years, this metric has ranged from a low of 97.37 to a high of 121.10. The Drug Manufacturers industry median Days Payable is 90.69. Alkaloid AD Skopje's value of 134.67 is 48.5% above this industry median. Based on the distribution chart, Alkaloid AD Skopje ranks #309 out of 921 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Alkaloid AD Skopje has a GF Score™ of 88/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Alkaloid AD Skopje's Days Payable compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Alkaloid AD Skopje ranks #309 out of 921 companies for Days Payable. This puts Alkaloid AD Skopje in the upper half of its industry. The industry median Days Payable is 90.69. Alkaloid AD Skopje's value of 134.67 is 48.5% above this benchmark. Historically, Alkaloid AD Skopje's own Days Payable has ranged from 97.37 to 121.10 over the past decade. While the company's 10-year median is 109.80 vs. the industry median of 90.69, Alkaloid AD Skopje has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.69, based on 921 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Alkaloid AD Skopje's current Days Payable of 134.67 is 48.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Alkaloid AD Skopje and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.69 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Alkaloid AD Skopje's current Days Payable is 134.67, which is 23% above median its own 10-year median of 109.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alkaloid AD Skopje stock overvalued right now?
Based on GuruFocus' analysis, Alkaloid AD Skopje (XMAE:ALK) is currently considered Modestly Undervalued. The stock's GF Value™ is MKD27,213.74, compared to a current price of MKD24,204.00 — trading 11.1% below its estimated fair value. The current Days Payable is 134.67, which is 23% above median its 10-year median of 109.80 and 48.5% above the Drug Manufacturers industry median of 90.69. Alkaloid AD Skopje's overall GF Score™ is 88/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Alkaloid AD Skopje (XMAE:ALK), the current Days Payable is 134.67 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Alkaloid AD Skopje (XMAE:ALK) Overvalued in 2026?
Based on GuruFocus' analysis, Alkaloid AD Skopje stock appears to be undervalued.
The current stock price of MKD24,204.00 is trading 11.1% below its estimated GF Value™ of MKD27,213.74.
GuruFocus considers Alkaloid AD Skopje to be Modestly Undervalued.
Key valuation signals for XMAE:ALK:
Days Payable: 134.67 (23% above median its 10-year median of 109.80)
GF Value™: MKD27,213.74 vs. price of MKD24,204.00 (11.1% below fair value)
Industry Position: 48.5% above the Drug Manufacturers median (#309 of 921)
No single metric tells the full story. See the XMAE:ALK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Alkaloid AD Skopje is engaged in producing and selling pharmaceutical, chemical and cosmetic products, as well as goods from the herbal origin. Its segments are Pharmaceuticals, Chemicals, Cosmetics and Botanicals. It derives maximum revenue from Pharmaceuticals products segment.
88GF Score
Get the complete analysis for XMAE:ALK
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XMAE:ALK has been successfully added to your 
